
Bioorganic and Medicinal Chemistry Letters p. 4274 - 4279 (2009)
Update date:2022-08-03
Topics:
Berglund, Susanne
Egner, Bryan J.
Graden, Henrik
Graden, Joakim
Morgan, David G.A.
Inghardt, Tord
Giordanetto, Fabrizio
The discovery and optimization of piperidin-4-yl-urea derivatives as MCH-R1 antagonists is herein described. Previous work around the piperidin-4-yl-amides led to the discovery of potent MCH-R1 antagonists. However, high affinity towards the hERG potassium channel proved to be an issue. Different strategies to increase hERG selectivity were implemented and resulted in the identification of piperidin-4-yl-urea compounds as potent MCH-R1 antagonists with minimized hERG inhibition.
View MoreAnhui Asahikasei Chemical Co., Ltd
Contact:86-551-4259770
Address:No. 88 Linquan Road Hefei Anhui China
Hebei Lead Bio-Chemicals Co., Ltd.
website:http://www.ldbiochem.com
Contact:+86-311-87826503
Address:481, Heping West Road, Shijiazhuang,China
Suzhou Lixin Pharmaceutical Co., Ltd.
Contact:86-512-88169812
Address:21 Tangxi Road, Suzhou New District, Suzhou 215151
Hangzhou LINGEBA Technology Co., Ltd.
Contact:+0086-571-87389059
Address:Office 1-913,NewYouth Plaza, GongShu Area, HangZhou,ZheJiang,P.R.China
Penglai Qianwei Chemical Co., Ltd.
Contact:86-535-3357802
Address:Shahelu (north), Penglai, Shandong, China
Doi:10.1055/s-0029-1216813
(2009)Doi:10.1002/anie.200902216
()Doi:10.1002/adsc.200800702
(2009)Doi:10.1016/j.tet.2009.06.055
(2009)Doi:10.1016/j.tetlet.2009.06.072
(2009)Doi:10.1002/anie.201600785
(2016)